Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

33.00

-0.42 (-1.26%)

Apr 25, 2025, 4:00 PM EDT - Market closed

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Apr '25 Apr 25, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2019
Market Capitalization	231	5	6	20	85	-	Upgrade
Market Cap Growth	3397.75%	-18.98%	-70.74%	-75.79%	-	-	Upgrade
Enterprise Value	189	0	0	14	67	-	Upgrade
Last Close Price	32.71	1.17	1.60	6.15	35.71	-	Upgrade
PB Ratio	5.74	1.19	1.23	2.67	5.51	-	Upgrade
P/TBV Ratio	5.74	1.19	1.23	2.67	5.52	-	Upgrade
Debt / Equity Ratio	0.00	0.02	0.01	0.01	-	-	Upgrade
Quick Ratio	125.59	10.92	24.16	8.00	31.12	5.30	Upgrade
Current Ratio	126.15	11.32	24.26	8.11	31.38	5.82	Upgrade
Return on Equity (ROE)	-3.35%	-46.18%	-86.02%	-99.95%	-85.94%	-124.04%	Upgrade
Return on Assets (ROA)	-4.93%	-25.19%	-47.45%	-57.32%	-51.52%	-61.70%	Upgrade
Return on Capital (ROIC)	-5.02%	-26.53%	-51.86%	-61.21%	-53.54%	-76.64%	Upgrade
Earnings Yield	-0.32%	-42.70%	-90.90%	-53.20%	-8.09%	-	Upgrade
Buyback Yield / Dilution	-29.26%	-15.87%	-50.58%	-37.64%	-148.42%	-74.24%	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q